Where conviction meets capital
Hand-built thematic portfolios from the trends shaping the next decade, AI, energy, reshoring, and longevity, alongside live-tracked books from the world's sharpest investors and political insiders. Every idea comes with the full thesis, the data, and the trades behind it.
Featured
Our highest-conviction book right now, with the full thesis and live performance.
Defense Primes
A concentrated book of US and allied primes, aerospace structures, and mission electronics.
We own the platform integrators and the irreplaceable sub-tier suppliers behind them. The thesis rests on a multi-year upward revision to defense outlays across NATO and the Indo-Pacific, coupled with an aerospace production cycle that is still rebuilding after a decade of under-investment. We are not betting on any single program win.
Energy Materials
A decade of under-investment meets AI-driven electricity demand and geopolitical supply shocks.
Ag
A concentrated book of fertilizer producers, grain traders, and row-crop equipment at cycle-trough multiples.
Coal
A thin, deliberately concentrated book across metallurgical, thermal, royalty, and coke-adjacent names.
Copper
A concentrated book of diversified miners, copper pure-plays, and lithium names at cycle-trough valuations.
AI Revolution
The capex wave rewiring the economy, from the chips and power grid that train frontier models to the software and robotics they touch.
AI in Drug Discovery
If computational screening lifts preclinical-to-Phase-II success by even a few hundred basis points, the economics rewrite.
AI Memory & Storage
HBM is supply-constrained, nearline HDD refresh is inflecting, and the surviving vendors trade at mid-cycle multiples on early-cycle earnings.
AI-Native SaaS: The Four Survivors
A deliberately narrow book of application-layer names that beat SPY through the 2024 rerating.
Longevity Healthcare
GLP-1, genomics, devices, and the demographic inflection behind durable long-run demand.
Cardio-Metabolic Franchise
Devices, diagnostics, and monitoring that benefit from GLP-1 pull-through without being drug makers.
CDMO and Biopharma Services
A concentrated book of tools, services, and diagnostics that sell into every therapeutic modality.
Dental, Vision & Elective Care
Elective-care franchises priced for a rates cycle that has already turned.
American Renaissance
Reshoring, defense rearmament, and domestic industrial capacity rebuilding the American production base.
Critical Minerals
Copper, gold, silver, aluminum and rare earths held through producers and royalty books.
Domestic Semiconductors
Analog, mixed-signal, and trailing-node names with US manufacturing footprint.
Engineering & Construction
Specialty contractors and mechanical integrators pricing the industrial buildout.
Defensive Income
Duration proxy for retirees reallocating from cash.
Energy Transition
Nuclear, gas, and grid — not pure solar and wind.
Japan
TSE reforms are structural — this is not a tactical yen trade.
Quality
Wide-moat businesses trading below their 5-year average multiple.